Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
ELV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$273.71 - $534.35
Previous CloseN/A
Volume477.50K
Average Volume (3M)2.06M
Market Cap
$71.58B
Enterprise Value$118.14B
Total Cash (Recent Filing)$33.86B
Total Debt (Recent Filing)$30.19B
Price to Earnings (P/E)13.5
Beta0.26
Next Earnings
Oct 15, 2025EPS Estimate
5.19Last Dividend Ex-Date
Sep 10, 2025Dividend Yield2.07%
Share Statistics
EPS (TTM)8.84
Shares Outstanding225,178,300
10 Day Avg. Volume2,132,403
30 Day Avg. Volume2,062,620
Financial Highlights & Ratios
PEG Ratio8.48
Price to Book (P/B)2.08
Price to Sales (P/S)0.49
P/FCF Ratio18.87
Enterprise Value/Market Cap1.65
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit0.62
Enterprise Value/Ebitda11.97
Forecast
1Y Price Target
$361.47Price Target Upside10.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Bulls Say, Bears Say
Bulls Say
Business PerformanceCommercial and Medicare businesses are performing in line with expectations, a positive given the pressure these business lines saw earlier.
Growth In CarelonFor Carelon, ELV is expecting to see 50% growth in 2025, while still expecting an operating margin for the business in the range of 3.0%-3.5%.
Tax BenefitsA favorable tax item to be recorded in the 4th quarter of this year is the largest unusual item and represents more than $1 of EPS.
Bears Say
Market VolatilityVolatility in Medicaid will continue with membership losses, with work requirements and reverifications adding additional uncertainty to forecasting the risk pool and margins.
Medicaid ChallengesManagement commented on a softer Medicaid recovery outlook.
Medicaid MarginsELV is no longer expecting to see margin improvement in the Medicaid business due to further disenrollment of low acuity members, leading to elevated cost trends.
Elevance Health News
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $273.71 and its highest was $534.35 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is $71.58B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Oct 15, 2025 which is in 20 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Jul 17, 2025. The company reported $8.84 earnings per share for the quarter, missing the consensus estimate of $8.909 by -$0.069.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.71 which represents an annual dividend yield of 2.07%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 5.19.
How many shares outstanding does Elevance Health have?
Elevance Health has 225,178,300 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $8.84 in its last earnings report, missing expectations of $8.909. Following the earnings report the stock price went down -12.218%.
Which hedge fund is a major shareholder of Elevance Health?
Currently, no hedge funds are holding shares in ELV
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$361.47 (10.75% Upside)
$361.47 (10.75% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 94%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.25%
12-Months-Change
Fundamentals
Return on Equity
12.48%
Trailing 12-Months
Asset Growth
7.92%
Trailing 12-Months
Company Description
Elevance Health
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
ELV Company Deck
ELV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging environment with significant pressures in the ACA and Medicaid markets leading to a downward revision of the full-year outlook. Despite strong revenue growth and segment expansion, the persistent elevated cost trends and revised guidance indicate a cautious approach towards recovery.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$361.47
▲(10.75% Upside)
Technical Analysis
Ownership Overview
0.15% Insiders
27.88% Mutual Funds
28.01% Other Institutional Investors
21.92% Public Companies and Individual Investors